|
tips |
publicēšana |
| 339 |
Žurnāls |
Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.
Stability of heroin hydrochloride in infusion devices and containers for intravenous administration.
Am J Hosp Pharm 1990 ; 47: 377-381. |
| 484 |
Žurnāls |
Northcott M, Allsopp MA, Powell H, Sewell GJ.
The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions.
J Clin Pharm Ther 1991 ; 16: 123-129. |
| 506 |
Žurnāls |
Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P.
Diamorphine stability in aqueous solution for subcutaneous infusion.
J Pharm Pharmacol 1989 ; 41: 275-277. |
| 512 |
Žurnāls |
Barnes AR, Nash S.
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Pharm World Sci 1995 ; 17: 87-92. |
| 779 |
Žurnāls |
Collins AJ, Abethell JA, Holmes SG, Rain R.
Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration.
J Pharm Pharmacol 1986 ; 38: 51P. |
| 788 |
Žurnāls |
Regnard CFB, Mannix K.
Subcutaneous drug compatibility in palliative care.
Lancet 1989 ; 2 (8670): 1044-1045. |
| 1230 |
Žurnāls |
Regnard C, Pashley S, Westrope F.
Anti-emetic / diamorphine mixture compatibility in infusion pumps.
Br J Pharm Pract 1986 ; 8: 218-220. |
| 1232 |
Žurnāls |
Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236. |
| 1288 |
Žurnāls |
Allwood MC, Brown PW, Lee M.
Stability of injections containing diamorphine and midazolam in plastic syringes.
Int J Pharm Pract 1994 ; 3: 57-59. |
| 1292 |
Žurnāls |
Grassby PF, Roberts DE.
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Int J Pharm Pract 1995 ; 3: 174-177. |
| 1385 |
Žurnāls |
Kirk B, Hain WR.
Diamorphine injection BP incompatibility.
Pharm J 1985 ; 235: 171. |
| 1388 |
Žurnāls |
Page J, Hudson S.
Diamorphine hydrochloride compatibility with saline.
Pharm J 1982 ; 228: 238-239. |
| 1886 |
Žurnāls |
Allwood MC.
The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes.
Palliative Med 1991 ; 5: 330-333. |
| 2051 |
Žurnāls |
Sanchez del Aguila MJ, Jones MF, Vohra A.
Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability.
Br J Anaesth 2003 ; 90: 179-182. |
| 2307 |
Žurnāls |
Kreeger L, Cowin P, Noble-Gresty J, Naysmith A.
Epidural diamorphine and bupivacaine stability study.
Palliative Med 1995 ; 9, 4: 315-318. |
| 2308 |
Žurnāls |
Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M.
Stability of premixed syringes of diamorphine and hyperbaric bupivacaine.
Int J Obstet Anesth 2005 ; 14, 4: 284-287. |
| 2404 |
Žurnāls |
Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J.
The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes
Palliative Med 2000 ; 14: 205-208. |
| 3184 |
Laboratorija |
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
CP Pharmaceuticals 2005 |
| 3504 |
Laboratorija |
Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012 |
| 4982 |
Laboratorija |
Diamorphine Hydrochloride 100mg for Injection - Summary of Product Characteristics Updated 06-May-2020.
Wockhardt UK Ltd 2020 |
